Home / Inspections / 1013039

FDA Inspection 1013039 — Zhejiang Haisen Pharmaceutical Co., Ltd.

Zhejiang Haisen Pharmaceutical Co., Ltd. — FEI 3003967524

The FDA completed an inspection of Zhejiang Haisen Pharmaceutical Co., Ltd. on April 21, 2017 in Dongyang. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Veterinary.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
April 21, 2017
Fiscal Year
2017
Product Type
Veterinary
Project Area
Pre-Approval Eval. of Animal Drugs and Food Additives
Location
Dongyang (China)

Facility

Other inspections at this facility

  • 1255806 (VAI Fri Nov 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1049416 (OAI Wed Apr 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 910004 (NAI Fri Dec 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources